A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis
Clinical Trial Grant
Administered By
Anesthesiology, Women's
Awarded By
Heron Therapeutics, Inc.
Start Date
July 8, 2021
End Date
May 10, 2022
Administered By
Anesthesiology, Women's
Awarded By
Heron Therapeutics, Inc.
Start Date
July 8, 2021
End Date
May 10, 2022